Category Archives: Genetic Engineering

"Genetic Engineering" is a song by British band Orchestral Manoeuvres in the Dark, released as the first single from their fourth studio album Dazzle Ships. Frontman Andy McCluskey has noted that the song is not an attack on genetic engineering, as many assumed at the time, including veteran radio presenter Dave Lee Travis upon playing the song on BBC Radio 1. McCluskey stated: "I was very positive about the subject. People didn't listen to the lyrics...I think they automatically assumed it would be anti."[2]

Charting at number 20 on the UK Singles Chart, "Genetic Engineering" ended the band's run of four consecutive Top 10 hits in the UK. It was also a Top 20 hit in several European territories, and peaked at number 5 in Spain. It missed the United States Billboard Hot 100 but made number 32 on the Mainstream Rock chart. US critic Ned Raggett retrospectively lauded the "soaring", "enjoyable" single in a positive review of Dazzle Ships for AllMusic, asserting: "Why it wasn't a hit remains a mystery."[3]

Critics in prominent music publications have suggested that the first 45 seconds of the song were a direct influence on Radiohead's "Fitter Happier", which appears on that band's 1997 album OK Computer.[3][4][5] Theon Weber in Stylus argued that the Radiohead track is "deeply indebted" to "Genetic Engineering".[4] The synthesized speech featured on the track is taken from a Speak & Spell, an educational electronic toy developed by Texas Instruments in the 1970s intended to teach children with spelling.

The new song "4-Neu" was featured on the B side of both the 7" and 12" versions. The song was not included on the Dazzle Ships album and remained exclusive to this release until its inclusion in the Navigation: The OMD B-Sides album in 2001 and then on the remastered special edition of Dazzle Ships in 2008. The song continues the band's tradition of including more experimental tracks as B sides to singles. The song title is a tribute to 70's German band Neu!, a Krautrock band that were an important influence on Andy McCluskey and Paul Humphreys prior to OMD.[6] "4-Neu" was never performed live until the special performance of Dazzle Ships at The Museum of Liverpool in November 2014 and at the Dazzle Ships / Architecture & Morality live performances in London and Germany in May 2016.[7]

Side one

Side two

Side one

Side two

A promotional video for Genetic Engineering was made and is included on the Messages - Greatest Hits CD/DVD release (2008).

Apart from the extended '312mm version' the band also recorded the song for a John Peel radio session in 1983. This version was made available on the Peel Sessions 1979-1983 album release (2000).

OMD played the song live on The Tube during its first series in February 1983.

The song was performed live during the Dazzle Ships promotional tour but rarely since then, until more recent live performances shows in 2014 and 2016.[12]

"Genetic Engineering" was covered by indie rock band Eggs and released as a single in 1994.[13]

It was also covered by Another Sunny Day as a limited edition single in 1989 and as an extra track on the re-release of on their 'London Weekend' album.

Optiganally Yours recorded a cover for a "very low-key tribute compilation".[14]

More recently, it has been covered by the indie rock band Oxford Collapse as part of the Hann-Byrd EP released in 2008.

Link:
Genetic Engineering (song) - Wikipedia, the free encyclopedia

Genetic Engineering (GE) is a highly complicated and advanced branch of science which involves a wide range of techniques used in changing the genetic material in the DNA code in a living organism. 'Genetic Engineering' means the deliberate modification of the characters of an organism by the manipulation of its genetic material.Genetic engineering comes under the broad heading of Biotechnology. There is a great scope in this field as the demand for genetic engineers are growing in India as well as abroad.

A cell is the smallest living unit, the basic structural and functional unit of all living matter, whether a plant, an animal, humans or a fungus. While some organisms are single celled, others like plants, animals, humans etc are made up of a lot more cells. For eg humans have approximately 3 million cells. A cell is composed of a 'cell membrane' enclosing the whole cell, many 'organelles' equivalent to the organs in the body and a 'nucleus' which is the command centre of the cell. Inside the nucleus are the chromosomes which is the storage place for all genetic (hereditary) information which determines the nature and characteristics of an organism. This information is written along the thin thread, called DNA, a nucleic acid which constitutes the genes (units of heredity). The DNA governs cell growth and is responsible for the transmission of genetic information from one generation to the next.

Genetic engineering aims to re-arrange the sequence of DNA in gene using artificial methods. The work of a genetic engineer involves extracting the DNA out of one organism, changing it using chemicals or radiation and subsequently putting it back into the same or a different organism. For eg: genes and segments of DNA from one species is taken and put into another species. They also study how traits and characteristics are transmitted through the generations, and how genetic disorders are caused. Their research involves researching the causes and discovering potential cures if any.

Genetic engineering have specialisations related to plants, animals and human beings. Genetic engineering in plants and animals may be to improve certain natural characteristics of value, to increase resistance to disease or damage and to develop new characteristics etc. It is used to change the colour, size, texture etc of plants otherwise known as GM (Genetically Modified) foods.GE in humans can be to correct severe hereditary defects by introducing normal genes into cells in place of missing or defective ones.

Here is the original post:
Genetic Engineering Careers in India : How to become a ...

A portrait of Khan Noonien Singh, a man who was a product of genetic engineering

Genetic engineering, or genetic manipulation was a process in which the DNA of an organism was selectively altered through artificial means. Genetic engineering was often used to produce "custom" organisms, such as for agricultural or medical purposes, as well as to produce biogenic weapons. The most common application of genetic engineering on intelligent beings in the Federation was corrective DNA resequencing for genetic disorders. A far more dubious application of genetic engineering was the genetic enhancement of individuals to produce improved senses, strength, intelligence, etc.

During Earth's 20th century, efforts to produce "superhumans" resulted in the Eugenics Wars. Genetically engineered individuals such as Khan Noonien Singh attempted to seize power. (TOS: "Space Seed")

This would lead to the banning of genetic engineering on Earth by the mid-22nd century, even research which could be used to cure critical illnesses. This ban was implemented because of the general fear of creating more tyrants such as Khan. It was also felt that parents would feel compelled to have their children genetically engineered, especially if "enhanced" individuals were allowed to compete in normal society.

Some, including geneticist Arik Soong, argued that it was simply convenient for humanity to denounce the attempts at genetic "improvement" of humanity, that it was inherently evil because of the Eugenics Wars. He argued that the source of the problem, in fact, wasn't the technology, but humanity's own inability to use it wisely. Imprisoned for, among other crimes, stealing the embryos of a number of Augment children, Soong wrote long treatises on the subject of genetic augmentations and improvements. His works were routinely taken and placed into storage (although his jailers often told him that his work was vaporized). Captain Jonathan Archer expressed his hope to Soong that research into genetic engineering that could cure life-threatening diseases would someday be resumed. (ENT: "Borderland", "The Augments")

Others, however, chose to establish isolated colonies, as became the case with the Genome colony on Moab IV, which was established in 2168. It became a notable and successful example of Human genetic engineering in which every individual was genetically tailored from birth to perform a specific role in society. However, after a five-day visit by the USS Enterprise-D when the ship came to the colony in an effort to save it from an approaching neutron star which, eventually, the craft was able to effectively redirect twenty-three colonists left the colony aboard the craft, possibly causing significant damage to the structure of their society. The reason for the societal split was that those who left the colony had realized their organized, pre-planned world had certain limitations, lacking opportunities to grow that were offered by the Enterprise. (TNG: "The Masterpiece Society")

By the 24th century, the United Federation of Planets allowed limited use of genetic engineering to correct existing genetically related medical conditions. Persons known to be genetically enhanced, however, were not allowed to serve in Starfleet, and were especially banned from practicing medicine. (TNG: "Genesis", DS9: "Doctor Bashir, I Presume")

Nevertheless, some parents attempted to secretly have their children genetically modified. (DS9: "Doctor Bashir, I Presume") Unfortunately, most of these operations were performed by unqualified physicians, resulting in severe psychological problems in the children due to their enhancements being only partially successful, such as a patient's senses being enhanced while their ability to process the resulting data remained at a Human norm. (DS9: "Statistical Probabilities")

In some cases, genetic engineering can be permitted to be performed in utero when dealing with a developing fetus to correct any potential genetic defects that could handicap the child as they grew up. Chakotay's family history included a defective gene that made those who possessed it prone to hallucinations, the gene afflicting his grandfather in Chakotay's youth, although the gene was suppressed in Chakotay himself. (VOY: "The Fight") In 2377, The Doctor performed prenatal genetic modification on Miral Paris to correct a spinal deviation, a congenital defect that tends to run in Klingon families; Miral's mother had undergone surgery to correct the defect in herself at a young age. (VOY: "Lineage")

Go here to read the rest:
Genetic engineering - Memory Alpha, the Star Trek Wiki

Genetic engineering is the process of removing a gene from one organism and putting it into another. Often, the removed genes are put into bacteria or yeast cells so that scientists can study the gene or the protein it produces more easily. Sometimes, genes are put into a plant or an animal.

One of the first genetic engineering advances involved the hormone insulin. Diabetes, a medical condition that affects millions of people, prevents the body from producing enough insulin necessary for cells to properly absorb sugar. Diabetics used to be treated with supplementary insulin isolated from pigs or cows. Although this insulin is very similar to human insulin, it is not identical. Bovine insulin is antigenic in humans. Antibodies produced against it would gradually destroy its efficacy.

Scientists got around the problem by putting the gene for human insulin into bacteria. The bacteria's cellular machinery, which is identical to the cellular machinery of all living things, "reads" the gene, and turns it into a protein-human insulin-through a process called translation.

View post:
Interactives . DNA . Genetic Engineering

genetic engineering,the artificial manipulation, modification, and recombination of DNA or other nucleic acid molecules in order to modify an organism or population of organisms.

The term genetic engineering initially meant any of a wide range of techniques for the modification or manipulation of organisms through the processes of heredity and reproduction. As such, the term embraced both artificial selection and all the interventions of biomedical techniques, among them artificial insemination, in vitro fertilization (e.g., test-tube babies), sperm banks, cloning, and gene manipulation. But the term now denotes the narrower field of recombinant DNA technology, or gene cloning (see Figure), in which DNA molecules from two or more sources are combined either within cells or in vitro and are then inserted into host organisms in which they are able to propagate. Gene cloning is used to produce new genetic combinations that are of value to science, medicine, agriculture, or industry.

DNA is the carrier of genetic information; it achieves its effects by directing the synthesis of proteins. Most recombinant DNA technology involves the insertion of foreign genes into the plasmids of common laboratory strains of bacteria. Plasmids are small rings of DNA; they are not part of the bacteriums chromosome (the main repository of the organisms genetic information). Nonetheless, they are capable of directing protein synthesis, and, like chromosomal DNA, they are reproduced and passed on to the bacteriums progeny. Thus, by incorporating foreign DNA (for example, a mammalian gene) into a bacterium, researchers can obtain an almost limitless number of copies of the inserted gene. Furthermore, if the inserted gene is operative (i.e., if it directs protein synthesis), the modified bacterium will produce the protein specified by the foreign DNA.

A key step in the development of genetic engineering was the discovery of restriction enzymes in 1968 by the Swiss microbiologist Werner Arber. However, type II restriction enzymes, which are essential to genetic engineering for their ability to cleave a specific site within the DNA (as opposed to type I restriction enzymes, which cleave DNA at random sites), were not identified until 1969, when the American molecular biologist Hamilton O. Smith purified this enzyme. Drawing on Smiths work, the American molecular biologist Daniel Nathans helped advance the technique of DNA recombination in 197071 and demonstrated that type II enzymes could be useful in genetic studies. Genetic engineering itself was pioneered in 1973 by the American biochemists Stanley N. Cohen and Herbert W. Boyer, who were among the first to cut DNA into fragments, rejoin different fragments, and insert the new genes into E. coli bacteria, which then reproduced.

Genetic engineering has advanced the understanding of many theoretical and practical aspects of gene function and organization. Through recombinant DNA techniques, bacteria have been created that are capable of synthesizing human insulin, human growth hormone, alpha interferon, a hepatitis B vaccine, and other medically useful substances. Plants may be genetically adjusted to enable them to fix nitrogen, and genetic diseases can possibly be corrected by replacing bad genes with normal ones. Nevertheless, special concern has been focused on such achievements for fear that they might result in the introduction of unfavourable and possibly dangerous traits into microorganisms that were previously free of theme.g., resistance to antibiotics, production of toxins, or a tendency to cause disease.

The new microorganisms created by recombinant DNA research were deemed patentable in 1980, and in 1986 the U.S. Department of Agriculture approved the sale of the first living genetically altered organisma virus, used as a pseudorabies vaccine, from which a single gene had been cut. Since then several hundred patents have been awarded for genetically altered bacteria and plants.

Read more:
genetic engineering | Britannica.com

Genetic engineering (GE for short) is about scientists altering the 'recipes' for making life the genes which you find in all living things. Doing this is very clever and seems to be very useful. Back in the 1990s, many 'Greens' campaigned against genetic engineering and still do. They predicted disaster but that hasn't happened. Nobody has died from eating genetically modified (GM) food. They were also worried about the private GE companies' ownership of the recipes genes for making these new life forms. So is genetic engineering okay? My guide explains the basics but it's up to you to make up your own mind about GE.

Finding your way around my GE Guide You can jump to any part that interests you from the table below. If you want to start at the beginning, click the green arrow below (forward to 'Genes, snails and whales').

Table of contents

Genes, snails and whales What makes you human or me a penguin? What are genes?

Tried and tested Life on Earth has been around for a long time so it's been well tested.

Adapt or die Only the fittest life survives. Here's how it does it.

Coils and corkscrews About that incredible stuff DNA.

Copycat: How DNA copies itself.

Read more from the original source:
Genetic engineering: a guide for kids by Tiki the Penguin

IMAGE:This is Charles Gersbach, assistant professor of biomedical engineering at Duke University. view more

DURHAM, N.C. -- Duke researchers have developed a new method to precisely control when genes are turned on and active.

The new technology allows researchers to turn on specific gene promoters and enhancers -- pieces of the genome that control gene activity -- by chemically manipulating proteins that package DNA. This web of biomolecules that supports and controls gene activity is known as the epigenome.

The researchers say having the ability to steer the epigenome will help them explore the roles that particular promoters and enhancers play in cell fate or the risk for genetic disease and it could provide a new avenue for gene therapies and guiding stem cell differentiation.

The study appears online April 6 in Nature Biotechnology.

"The epigenome is everything associated with the genome other than the actual genetic sequence, and is just as important as our DNA in determining cell function in healthy and diseased conditions," said Charles Gersbach, assistant professor of biomedical engineering at Duke. "That becomes immediately obvious when you consider that we have over 200 cell types, and yet the DNA in each is virtually the same. The epigenome determines which genes each cell activates and to what degree."

This genetic puppetmaster consists of DNA packaging proteins called histones and a host of chemical modifications -- either to these histones or the DNA itself -- that help determine whether a gene is on or off.

But Gersbach's team didn't have to modify the genes themselves to gain some control.

"Next to every gene is a DNA sequence called a promoter that controls its activity," explained Gersbach. "But there's also many other pieces of the genome called enhancers that aren't next to any genes at all, and yet they play a critical role in influencing gene activity too."

Timothy Reddy, assistant professor of biostatistics and bioinformatics at Duke, has spent the better part of a decade mapping millions of these enhancers across the human genome. There has not, however, been a good way to find out exactly what each one does. An enhancer might affect a gene next door or several genes across the genome -- or maybe none at all.

Read the rest here:
Pulling the strings of our genetic puppetmasters

Bayers Marijn Dekkers (Christof Koepsel/Getty Images)

TOP STORIES

Endure if you must The Washington Posts takeout on tech gurus and venture capitalists with too much time on their hands trying to extend life (though most of the possible stuff they talk about are simply medical treatments not invented). Accompanying the story is a somewhat interesting game The Post created in which you drag stem cells into your brain and so on to extend your life.

I know its a week away but you should probably start watching the HIMSS 2015 hashtag now.

LIFE SCIENCE

A long but worthwhile read on a moratorium and proper path toward human genetic engineering.

In the long run, I believe the permissibility of using germline genomic modification to make babies will be, and should be, a political issue. Right now, I suspect I would opt for regulating it on a safety/benefit basis, allowing it only when the potential benefits outweighed the risks. But I might change my mind, either because of newly discovered facts or well-made arguments. Importantly, though I do not think that my view should govern. The people, through their governments, should govern.

Medtronic has invested $2 million in DreaMed Diabetes and will be using its artificial pancreas technology in is insulin pumps.

I hope you didnt miss The Wall Street Journals look at Bayer and its continued focus on its health and agriculture businesses. Bayer is dumping its $10 billion specialty plastics business.

Still, some analysts are skeptical that Bayers drug pipeline is strong enough to deliver many new products with selling power like the current wave. But Bayer expects at least three new drugs in midstage clinical testing, including two for chronic heart failure, to advance this year. Strong data is expected for those trials, said Ali Al-Bazergan, an analyst at Datamonitor Healthcare in London.

Originally posted here:
Going deep on life extension investments and human genetic engineering (Morning Read)

(New York - March 25, 2015) Induced pluripotent stem cells (iPSCs) -- adult cells reprogrammed back to an embryonic stem cell-like state--may better model the genetic contributions to each patient's particular disease. In a process called cellular reprogramming, researchers at Icahn School of Medicine at Mount Sinai have taken mature blood cells from patients with myelodysplastic syndrome (MDS) and reprogrammed them back into iPSCs to study the genetic origins of this rare blood cancer. The results appear in an upcoming issue of Nature Biotechnology.

In MDS, genetic mutations in the bone marrow stem cell cause the number and quality of blood-forming cells to decline irreversibly, further impairing blood production. Patients with MDS can develop severe anemia and in some cases leukemia also known as AML. But which genetic mutations are the critical ones causing this disease?

In this study, researchers took cells from patients with blood cancer MDS and turned them into stem cells to study the deletions of human chromosome 7 often associated with this disease.

"With this approach, we were able to pinpoint a region on chromosome 7 that is critical and were able to identify candidate genes residing there that may cause this disease," said lead researcher Eirini Papapetrou, MD, PhD, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai.

Chromosomal deletions are difficult to study with existing tools because they contain a large number of genes, making it hard to pinpoint the critical ones causing cancer. Chromosome 7 deletion is a characteristic cellular abnormality in MDS and is well-recognized for decades as a marker of unfavorable prognosis. However, the role of this deletion in the development of the disease remained unclear going into this study.

Understanding the role of specific chromosomal deletions in cancers requires determining if a deletion has observable consequences as well as identifying which specific genetic elements are critically lost. Researchers used cellular reprogramming and genome engineering to dissect the loss of chromosome 7. The methods used in this study for engineering deletions can enable studies of the consequences of alterations in genes in human cells.

"Genetic engineering of human stem cells has not been used for disease-associated genomic deletions," said Dr. Papapetrou. "This work sheds new light on how blood cancer develops and also provides a new approach that can be used to study chromosomal deletions associated with a variety of human cancers, neurological and developmental diseases."

Reprogramming MDS cells could provide a powerful tool to dissect the architecture and evolution of this disease and to link the genetic make-up of MDS cells to characteristics and traits of these cells. Further dissecting the MDS stem cells at the molecular level could provide insights into the origins and development of MDS and other blood cancers. Moreover, this work could provide a platform to test and discover new treatments for these diseases.

###

This study was supported by grants from the National Institutes of Health, the American Society of Hematology, the Sidney Kimmel Foundation for Cancer Research, the Aplastic Anemia & MDS International Foundation, the Ellison Medical Foundation, the Damon Runyon Cancer Research Foundation, the University of Washington Royalty Research Fund, and a John H. Tietze Stem Cell Scientist Award.

More here:
Researchers discover genetic origins of myelodysplastic syndrome using stem cells

Contact Information

Available for logged-in reporters only

Newswise (New York March 25, 2015) Induced pluripotent stem cells (iPSCs)adult cells reprogrammed back to an embryonic stem cell-like statemay better model the genetic contributions to each patient's particular disease. In a process called cellular reprogramming, researchers at Icahn School of Medicine at Mount Sinai have taken mature blood cells from patients with myelodysplastic syndrome (MDS) and reprogrammed them back into iPSCs to study the genetic origins of this rare blood cancer. The results appear in an upcoming issue of Nature Biotechnology.

In MDS, genetic mutations in the bone marrow stem cell cause the number and quality of blood-forming cells to decline irreversibly, further impairing blood production. Patients with MDS can develop severe anemia and in some cases leukemia also known as AML. But which genetic mutations are the critical ones causing this disease?

In this study, researchers took cells from patients with blood cancer MDS and turned them into stem cells to study the deletions of human chromosome 7 often associated with this disease.

With this approach, we were able to pinpoint a region on chromosome 7 that is critical and were able to identify candidate genes residing there that may cause this disease, said lead researcher Eirini Papapetrou, MD, PhD, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai.

Chromosomal deletions are difficult to study with existing tools because they contain a large number of genes, making it hard to pinpoint the critical ones causing cancer. Chromosome 7 deletion is a characteristic cellular abnormality in MDS and is well-recognized for decades as a marker of unfavorable prognosis. However, the role of this deletion in the development of the disease remained unclear going into this study.

Understanding the role of specific chromosomal deletions in cancers requires determining if a deletion has observable consequences as well as identifying which specific genetic elements are critically lost. Researchers used cellular reprogramming and genome engineering to dissect the loss of chromosome 7. The methods used in this study for engineering deletions can enable studies of the consequences of alterations in genes in human cells.

Genetic engineering of human stem cells has not been used for disease-associated genomic deletions, said Dr. Papapetrou. This work sheds new light on how blood cancer develops and also provides a new approach that can be used to study chromosomal deletions associated with a variety of human cancers, neurological and developmental diseases.

Reprogramming MDS cells could provide a powerful tool to dissect the architecture and evolution of this disease and to link the genetic make-up of MDS cells to characteristics and traits of these cells. Further dissecting the MDS stem cells at the molecular level could provide insights into the origins and development of MDS and other blood cancers. Moreover, this work could provide a platform to test and discover new treatments for these diseases.

Original post:
Mount Sinai Researchers Discover Genetic Origins of Myelodysplastic Syndrome Using Stem Cells